FDA Approved: BORTEZOMIB — Original Application (Eugia US LLC)

View source ↗

Summary

The FDA approved the original application for a generic Bortezomib product from Eugia US LLC (ANDA212825).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma
• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

ORIG AP for BORTEZOMIB (BORTEZOMIB)